Nipah vaccine - Integrated BioTherapeutics
Latest Information Update: 30 Jun 2023
At a glance
- Originator Integrated BioTherapeutics
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Nipah virus infections
Most Recent Events
- 12 Jun 2023 Preclinical trials in Nipah virus infections (Prevention) in USA (unspecified route) (Integrated BioTherapeutics pipeline, June 2023)